POTUS just tweeted floated. Boats float and also things in the air we breathe. Which way are we thinking?
actually
"floating"
https://twitter.com/realDonaldTrump/status/1261793147069366279
Donald J. Trump
@realDonaldTrump
…..are therefore given massive advantages over The United States, and everyone else? Prior to the Plague floating in from China, our Economy was blowing everybody away, the best of any country, EVER. We will be there again, and soon!
3:58 PM · May 16, 2020·
PFCE?
Plague capitalized
floating
China
Economy capitalized
blowing
so much to dig on here?
which will it be?
OR BOTH?
Perfluorocarbon emulsion
(PFCE)-O 2 therapy attenuates the influx of neutrophils, T cells, and B cells into lungs of transgenic sickle cell (HbSS) mice but not C57BL/6 mice infected with Streptococcus pneumoniae. Fluorescence-activated cell sorter-determined neutrophil, macrophage, T-cell, and Bcell counts from lungs of HbSS (A, C, E, and G) and C57BL/6 (B, D, F, and H) mice infected with S. pneumoniae, managed in air or O 2 , and treated with PFCE or phosphate-buffered saline (PBS). Box and whisker plots represent ranges, with mean values shown by horizontal bars. Pneumococcus-infected HbSS mice treated with PFCE-O 2 had significantly lower pulmonary neutrophil, macrophage, T-cell, and B-cell counts (A, C, E, and G) than infected HbSS littermates treated with PFCE-air. Pneumococcus-infected C57BL/6 mice treated with PFCE-O 2 had leukocyte counts similar to those of infected littermates treated with PFCE-air (B, D, F, and H). Pneumococcus-infected PFCE-air-or PFCE-O 2-treated C57BL/6 mice had significantly lower neutrophil and macrophage cell counts than PBS-air-or PBS-O 2-treated littermates (B and D). There were 6 animals in each treatment group. *P < .01.
Pefluorocarbon Emulsion Therapy Attenuates Pneumococcal Infection in Sickle Cell Mice.
Article
Full-text available
Nov 2014
Nawal Helmi
Peter W Andrew
Hitesh Pandya
Impaired immunity and tissue hypoxia-ischaemia are strongly linked with Streptococcus pneumoniae pathogenesis in patients with sickle cell anaemia. Perfluorocarbon emulsions (PFCE) have high O2 dissolving capacity and can alleviate tissue hypoxia. Here, we evaluate the effects of intravenous PFCE therapy in transgenic sickle cell (HbSS) mice infect…
https://www.researchgate.net/figure/Perfluorocarbon-emulsion-PFCE-O-2-therapy-attenuates-the-influx-of-neutrophils-T_fig5_268877933
https://www.google.com/search?q=pfce&source=lnms&tbm=isch&sa=X&ved=2ahUKEwil_JHOw7npAhUhIjQIHf0WDL8Q_AUoAnoECA0QBA&biw=1400&bih=901
so much to dig on re: POTUS floated Tweet China
PFCE Ceiling Convertible Decorative Fan Coil Unit
Production Capacity: 20, 000pcs/year
https://powergrand.en.made-in-china.com/product/ZqyJpfhGgarj/China-PFCE-Ceiling-Convertible-Decorative-Fan-Coil-Unit.html
https://www.made-in-china.com/
so much PFCE
https://www.google.com/search?q=pfce&source=lnms&tbm=isch&sa=X&ved=2ahUKEwil_JHOw7npAhUhIjQIHf0WDL8Q_AUoAnoECA0QBA&biw=1400&bih=901
if you just use the capitalized PCE
and
Dry Cleaners?
https://www.crainsnewyork.com/article/20160508/SMALLBIZ/160509884/perchloroethylene-used-by-new-york-city-dry-cleaners-under-the-name-perc-has-been-a-concern-for-decades-leading-t
What Makes Cleaning Up Perc Spills So Expensive?
Enviro Forensics
Environmental contamination is often associated with industrial sites and gas stations, but the dry cleaning solvent PCE is one of the more expensive contaminants to clean up. Here’s why it’s so expensive to clean up and what you can do about it.
Dry cleaners are keenly aware that the use of tetrachloroethene (PCE, known as Perc) in the textiles industry has become as heavily regulated as nearly any other industrial chemical to date. In fact, environmental concerns resulting from the current or past use of Perc are practically as common as those arising from old gasoline stations. Everyone has seen the vacant, seemingly valuable, corner lot that used to house a bustling gas station yet is now sitting in ruin. These old gas stations are known to have been the cause of environmental problems, and the high cost of the cleanup is often the reason why they go dormant for so long. Unfortunately, the amount of time and money that is required to investigate and ultimately clean up dry cleaner sites that have been impacted with Perc can be several times higher than at typical gas station sites. A common gas station site falls into the $350,000 range, and we have seen average closure costs for dry cleaner sites more in the $1 million to $1.25 million range. What makes Perc so much harder and more expensive to clean up than petroleum?
This article discusses a few of the complicating factors about Perc releases that make them so unique and so darn expensive.
-
Perc is Heavier than Water
Part of the reason that Perc releases are so challenging to investigate and cleanup is because of its chemical properties. PCE is over 60% heavier than water under normal conditions and sinks to the bottom while the groundwater floats on top. Likewise, when a release of Perc to the ground occurs and it reaches down to the groundwater table, it will continue to sink until it hits a layer of dense material, like clay.
It will sit there and continue to dissolve for a long time, which can cause a long groundwater contamination plume. The groundwater plume may also be very deep, depending on the geological conditions in your neighborhood. Big and deep means that more off-site properties are likely to be impacted as the plume grows. If multiple clay layers exist, there may be continuing sources of groundwater impacts.
Fact: Perc is heavy and can travel fast and far, which creates large plumes in groundwater.
Petroleum products, including gasoline, diesel fuel, Stoddard solvent, and the like, are less dense than water. In contrast to Perc releases, once a petroleum spill reaches the groundwater table it floats on top of the groundwater and migrates horizontally. As a result, most petroleum releases are fairly shallow and comparatively simple to investigate and cleanup.
-
PCE is Resistant to Natural Breakdown
-
PCE Vapors are Persistent and Mobile
https://www.enviroforensics.com/blog/what-makes-cleaning-up-perc-spills-so-expensive/
you get the communist party of Spain?
https://www.google.com/search?q=pce&source=lnms&tbm=isch&sa=X&ved=2ahUKEwiswOOVxrnpAhUhHjQIHbsyAGcQ_AUoBHoECBYQBg&biw=1400&bih=852
l E T 17 Retweeted
Suzanne alderman⭐️⭐️⭐️
@maga1Trump13
·
22m
Replying to
@Inevitable_ET
Could mean floating in the skies from chem trails 🧐or blowing in the skies.
https://twitter.com/maga1Trump13/status/1261799552601993222
https://twitter.com/Inevitable_ET/status/1261796346031255552
l E T 17
@Inevitable_ET
Did he say “floating in” ?
Is he telling us how it got here ?
Quote Tweet
Donald J. Trump
@realDonaldTrump
· 49m
…..are therefore given massive advantages over The United States, and everyone else? Prior to the Plague floating in from China, our Economy was blowing everybody away, the best of any country, EVER. We will be there again, and soon!
Kassie🕊
@KassandraKitson
·
33m
Replying to
@Inevitable_ET
PLAGUE is also the name of Dr Judy Mikovits book about how she found retroviruses in the vaccine supply & how Fauci is responsible for blackballing her & having her arrested
https://twitter.com/KassandraKitson/status/1261797618767859712
Deep Roller
@WrathOfDeep
Replying to
@KassandraKitson
and
@Inevitable_ET
She's also an expert on Gain-of-Function.
In other words, any selection process involving an alteration of genotypes and their resulting phenotypes is considered a type of Gain-of-Function (GoF) research, …
Gain of Function Research
Gain of Function Research
Certain gain-of-function studies with the potential to enhance the pathogenicity or transmissibility of potential pandemic pathogens (PPPs) have raised biosafety and biosecurity concerns, including the potential dual use risks associated with the misuse of the information or products resulting from such research.
On October 16, 2014, the White House Office of Science and Technology Policy announced the launch of the U.S. Government (USG) gain-of-function (GOF) deliberative process to re-evaluate the potential risks and benefits associated with certain GOF experiments. During this process the USG paused the release of federal funding for GOF studies anticipated to enhance the pathogenicity or transmissibility among mammals by respiratory droplets of influenza, MERS, or SARS viruses.
The NSABB served as the official federal advisory body on the GOF issue and was tasked with providing recommendations to the USG on a conceptual approach for evaluating proposed GOF research. The NSABB finalized its recommendations on May 24, 2016. The U.S. Government considered the NSABB’s findings and recommendations during the development of policy on gain-of-function research. In January 2017, the U.S. Government released policy guidance for the review and oversight of research anticipated to create, transfer, or use enhanced PPPs.
Department of Health and Human Services P3CO Framework
Department of Health and Human Services Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens
U.S. Government Policy on Enhanced PPP Research
Recommended Policy Guidance for Departmental Development of Review Mechanisms for Potential Pandemic Pathogen Care and Oversight
U.S. Government Gain-of-function Deliberative Process
NSABB Recommendations for the Evaluation and Oversight of Proposed Gain-of-Function Research
U.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS Viruses
FAQs on the U.S. government Gain-of-function Deliberative Process and Research Funding Pause
Symposia Summaries and Commissioned Reports
1st National Academies Symposium Summary (December 15-16, 2014) – Potential Risks and Benefits of Gain-of-Function Research: Summary of a Workshop
2nd National Academies Symposium Summary (March 10-11, 2016) – Gain-of-Function Research: Summary of the Second Symposium
Risk and Benefit Analysis of Gain of Function Research – Final Report (Gryphon Scientific)
Gain-of-Function Research: Ethical Analysis (Professor Michael J. Selgelid)
Additional Material
NIH Director’s Statement on Funding Pause on Certain Types of Gain-of-Function Research
NIH Director’s Statement on Lifting of NIH Funding Pause on Gain-of-Function Research
NIH Director’s Statement on NIH’s commitment to transparency on research involving potential pandemic pathogens
Supplemental Information on the Risk and Benefit Analysis of Gain-of-Function Research
Gain-of-Function Deliberative Process Written Public Comments (Nov 10, 2014 – June 8, 2016)
External Resources
S3: Science, Safety, and Security
https://twitter.com/WrathOfDeep/status/1261804568117207042
https://osp.od.nih.gov/biotechnology/gain-of-function-research/
read more here:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30006-9/fulltext
NEWSDESK| VOLUME 18, ISSUE 2, P148-149, FEBRUARY 01, 2018
PDF [267 KB]
Ban on gain-of-function studies ends
Talha Burki
Published:February, 2018DOI:https://doi.org/10.1016/S1473-3099(18)30006-9
Ban on gain-of-function studies ends
The US moratorium on gain-of-function experiments has been rescinded, but scientists are split over the benefits—and risks—of such studies.
On Dec 19, 2017, the US National Institutes of Health (NIH) announced that they would resume funding gain-of-function experiments involving influenza, Middle East respiratory syndrome coronavirus, and severe acute respiratory syndrome coronavirus. A moratorium had been in place since October, 2014. his process has now concluded. It was spearheaded by the National Science Advisory Board for Biosecurity (NSABB) and led to the development of a new framework for assessing funding decisions for research involving pathogens with enhanced pandemic potential. The release of the framework by the Department of Health and Human Services (HHS), of which NIH is part, signalled the end of the funding pause.